Fountain Tamara 4
4 · Sight Sciences, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) Director Tamara Fountain Receives RSU Award
What Happened
Tamara Fountain, a director of Sight Sciences, received a grant of 28,261 restricted stock units (RSUs) on June 4, 2026 under the company's Non-Employee Director Compensation Program. The RSUs were granted at $0.00 (award) and were valued at approximately $130,000 based on the closing price on the grant date. Each RSU represents a contingent right to receive one share of common stock; the award is compensation, not a cash purchase or sale.
Key Details
- Transaction date: June 4, 2026; Form 4 filed June 5, 2026 (timely filing). Transaction code: A (award).
- Grant amount: 28,261 RSUs; grant price reported as $0.00. Estimated value: ~ $130,000 (based on closing price on grant date).
- Vesting: RSUs vest on the earlier of June 4, 2027 or the date of the 2027 annual meeting, subject to continued service as a director.
- Shares owned after transaction (per filing): 81,389 shares of common stock and 28,261 RSUs (unvested).
- Footnote: Each RSU converts to one share upon vesting. No 10b5-1 plan, tax-withholding sale, or sale/purchase reported.
Context
RSU grants to directors are standard compensation and do not represent an open-market purchase (which some investors view as a stronger bullish signal). The award increases her potential future stake if the RSUs vest; until then they are contingent and typically carry no voting rights. This filing simply reports the grant; it does not indicate any sale or exercise of options.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-04+28,261→ 109,650 total
Footnotes (2)
- [F1]Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
- [F2]Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein.